INVESTOR PRESENTATION - INVION LIMITED
INVION LIMITED
Health Care
Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.
Market Cap
55.01m
Price at Close
$0.01
4w avg. Volume
1.16m
4w avg. Turnover
$10.57k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| - | 12 Aug 2020 |
| 0.00% | 07 Aug 2020 |
| 0.00% | 28 Jul 2020 |
| 0.00% | 28 Jul 2020 |
| 0.00% | 12 Jul 2020 |
| 0.00% | 30 Jun 2020 |
| +14.29% | 22 Jun 2020 |
| 0.00% | 20 Apr 2020 |
| 0.00% | 20 Apr 2020 |
| +12.50% | 14 Apr 2020 |
Market Data
Current Price
$0.01
52WK HIGH
$0.026
52WK LOW
$0.006
1YR RETURN
-37.50%
1YR RETURN VS. SECTOR
-59.63%
90 DAY RETURN
+25.00%
ASX RANK
953
/2,032
SECTOR RANK
13
/32
SHARES OUTSTANDING
5.50b
INVION LIMITED
Health Care
Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.
Market Cap
55.01m
Price at Close
$0.01
4w avg. Volume
1.16m
4w avg. Turnover
$10.57k
ASX:IVX is not raising right now
Want to invest?
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Contact Us
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia
(03) 9028 2888
deals@freshequities.com
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.